drugset
drugset / Trial / NCT00530790

Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome

NCT00530790 ↗

Phase 2 Completed 35 enrolled GlaxoSmithKline
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study was designed to evaluate the safety, pharmacokinetic profile and efficacy in Restless Legs Syndrome patients.

Timeline

Start
2007-08-23
Primary completion
2008-02-01
Completion
2008-02-01

Publications

  • Background GSK has concluded that it is not feasible to publish this study in a peer-reviewed scientific journal because the nature of the study is unlikely to be of interest to a journal. GSK is providing the attached study results summary with a conclusion.

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropinirole Small molecule — Oral

Indications

restless legs syndrome